A Dialogue Between Nasser Hanna, MD, and Steven Vogl, MD
Steven Vogl, MD
Medical Oncologist
New York, New York
Tom and Julie Wood Family Foundation Professor of Lung Cancer Clinical Research
Indiana University School of Medicine
Indianapolis, Indiana
ADAURA is a phase 3 randomized trial comparing adjuvant osimertinib with placebo in patients with surgically resected stage IB to IIIA non-small cell lung cancer (NSCLC) that harbors an activating EGFR mutation with